NEW YORK (Reuters Health) – It doesn’t matter whether or not EMTs do a few minutes’ CPR before defibrillation of cardiac-arrest patients, researchers conclude in a meta-analysis that…
NEW YORK (Reuters Health) – Despite being recommended by the American Heart Association, there is no evidence that immediate beta-blockade in patients with ST-segment elevation myocardial infarction (STEMI)…
NEW YORK (Reuters Health) – When spontaneous circulation is restored after cardiac arrest, patients with hyperoxia have higher rates of in-hospital mortality than those with hypoxia or normal…
Richard J Shemin, MD, Chief of Cardiothoracic Surgery, UCLA David Geffen School of Medicine, discusses the future of cardiothoracic surgery, which may see such innovations as the development…
NEW YORK (Reuters Health) – Combined bivalirudin (Angiomax) and vascular closure devices are better to staunch bleeding after percutaneous coronary intervention (PCI) than either strategy alone, according to…
NEW YORK (Reuters Health) – While a hypertension risk prediction model developed in the Framingham Heart Study (FHS) shows good discrimination, its performance is not significantly better than…
NEW YORK (Reuters Health) – Giving beta-blockers to patients with cocaine-associated chest pain appears to be safe and may even save lives, according to research in the May…
NEW YORK (Reuters Health) – Beta-blockers can improve survival and reduce exacerbations of chronic obstructive pulmonary disease (COPD) – even in patients with cardiovascular disease, a new study…
NEW YORK (Reuters Health) – Including tirofiban (Aggrastat) in pre-hospital protocols can improve the outcomes of angioplasty for ST-segment elevation myocardial infarction (STEMI), according to randomized trial results.…
NEW YORK (Reuters Health) – Heparin bridging while withholding warfarin before implantation of a heart rhythm device substantially increases the risk of bleeding, new research shows. By contrast,…